Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

199.51 +0.02 (+0.01%)
Official Closing Price Updated: 8:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Can March Swing Lows Hold?
The Nasdaq has registered two higher volume distribution days in the past four with the MACD clinging on to its earlier 'buy' trigger. 
Via Talk Markets
Topics Stocks / Equities
Wall Street Inches Up Ahead Of Tariff Day: What's Driving Markets Tuesday?
Following the worst quarterly performance for U.S. stocks in over two years, caution dominated Wall Street as investors awaited details on the tariff plans expected from the Trump administration on... 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
SPY, QQQ Draw Heavy Retail Activity After Market Marks Worst Quarterly Loss Since 2022
ouis Navellier expects the earnings season to give investors new confidence regarding the near-term gains of AI spending, potentially lifting sentiment toward tech stocks. 
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
Exposures Artificial Intelligence Economy Political
High-flying Gorilla Tech Stock In Spotlight After FY24 Revenue Beat, Guidance Reiteration: Retail Mood Flips To Positive
Revenue for the year improved 15.4% year over year (YoY) and exceeded the Finchat-compiled consensus of $71.22 million. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Progress Software Stock Rallies After-Hours On Beat-And-Raise Q1: Retail Mood Stays Depressed
Annualized recurring revenue, a key operating metric, jumped 48% YoY to $836 million, with the growth rate accelerating from the 46% pace in the previous quarter. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stocks Fall, S&P 500 Eyes Worst Month In Almost Two Years, Oil Rallies: What's Driving Markets Monday?
Risk sentiment remains under pressure at the start of the week on Wall Street, with tech-heavy indexes sliding while commodities advance, as traders fear a new wave of price pressures following the... 
Via Benzinga
Topics Stocks World Trade
Exposures Tariff US Equities
Amidst Corporate Buybacks And Margin Debt Dynamics
Through 4Q24, buybacks continued to act as a tailwind, while margin debt fell in February from January’s fresh record. 
Via Talk Markets
Topics Stocks / Equities
Progress Software Stock Trades In Bearish Territory Ahead Of Q1 Print: Retail Sentiment Hits Rock Bottom
The Finchat-compiled consensus estimates call for adjusted earnings per share (EPS) of $1.06 and revenue of $235.64 million for the first quarter of the fiscal year 2025. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Fresh Zig-Zag Low Targets For Indices With Russell 2000 In Crash Watch
With last week's move to the downside we now have to consider new swing lows for indices, with the ones established a couple of weeks ago unlikely to hold. 
Via Talk Markets
Topics Stocks / Equities
Elliott Wave Weekly Update: Dow 30 And Russell 2000
Continued downside is expected as the markets continue to move through the 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
CoT: Peek Into Future Through Futures, How Hedge Funds Are Positioned - Sunday, March 30
After 3 weeks of staying net long, hedge funds once again switched back to net short e-mini S&P500 futures. 
Via Talk Markets
Topics Bonds Futures Stocks / Equities
Technical Market Report For March 29, 2025
The positives are elusive. The breadth indicators show the possibility of a serious decline in prices in the near future. But at least the bottom for this decline should be easy to identify by a sharp... 
Via Talk Markets
Topics Stocks / Equities
It’s Getting Ugly
Analyzing the recent market correction as key technical levels break down. 
Via Talk Markets
Topics ETFs Stocks / Equities
Stocks: The Good, Bad, And The Ugly
In this week's video, we'll review the latest charts and data to help us understand the good, the bad, and the ugly in the stock market. 
Via Talk Markets
Topics Stocks / Equities
Inflation Fears Spark Risk-Off Sentiment As Magnificent 7 Drop: What's Driving Markets Friday?
Markets faltered on Friday, with Wall Street reeling as investors hurried to shed risk in the face of mounting inflation and tariff uncertainties. 
Via Benzinga
Topics Economy World Trade
Exposures Interest Rates Tariff
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish
Fourth-quarter loss per share came in at $0.16, lower than the $0.24 in the corresponding period of 2023, and below the consensus estimate of $0.25, according to FinChat data. 
Via Stocktwits
Topics Earnings
Exposures Financial Product Safety
Recession-Proof Stocks to Buy
Are we heading toward a recession? 
Via The Motley Fool
Topics Economy
Exposures Economy
SPY, QQQ See Strong Retail Activity On Stocktwits Ahead of Fed’s Key Inflation Gauge Release
Morgan Stanley expects the core monthly PCE rate to be 0.35%, rounding off to 0.4%, nudged higher by strong goods inflation and an acceleration in core services prices, excluding housing. 
Via Stocktwits
Topics ETFs Economy Government
Exposures Interest Rates Political Tariff
Russell 2000 Earnings Dashboard 24Q4 - Thursday, March 27
The 24Q4 Y/Y blended earnings growth estimate is 45.8%. If the energy sector is excluded, the growth rate for the index is 75.0%. 
Via Talk Markets
Topics Stocks / Equities
Stocks Slide As Auto Tariffs Boost Tesla, Rivian And Hit GM, Ford: What's Driving Markets Thursday?
Wall Street dipped slightly on Thursday, with all major indexes edging into the red as investors digested President Donald Trump‘s latest move on auto tariffs. 
Via Benzinga
Candel’s Final Survival Data From Lung Cancer Drug Trial Lifts Stock After-Hours, Fuels Retail Optimism
The study included 46 fully treated patients, with 37% of those with progressive disease still alive after two years. 
Via Stocktwits
Financial Markets Report For Wednesday, March 26
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Wednesday, March 26. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
Verint Stock Plunges After-Hours On Q4 Miss: Retail Fears More Weakness
Verint noted that ASC 606, a set of accounting rules governing how a company recognizes revenue from customer contracts, impacted its top- and bottom-line results. 
Via Stocktwits
S&P Marks A Resistance Rebound
The S&P had the picture-perfect reversal off resistance, undercutting its 200-day MA in the process. 
Via Talk Markets
Topics Cryptocurrencies Stocks Stocks / Equities
Exposures US Equities
Verint Stock Trades Flat Ahead Of Q4 Print: Retail’s Upbeat
At the Investor Day held in mid-January, the company said it has transitioned to a subscription model, with 80% of the revenue for the year coming from subscription offerings. 
Via Stocktwits
Stocks Slip As Tariff Fears Resurface: What's Driving Markets Wednesday?
U.S. stocks decline on renewed tariff concerns, technology shares lead selloff while blue-chip stocks are more resilient. VIX jumps 8%, dollar and Treasury yields remain flat. 
Via Benzinga
Topics Stocks World Trade
Exposures Tariff US Equities
Is Retail Willing To Play Market Volatility: Here’s What A Stocktwits Poll Reveals
Recent market volatility is a function of President Donald Trump’s tariff talks and the uncertainty surrounding monetary policy. 
Via Stocktwits
Topics Government World Trade
Exposures Political Tariff
Lumen Analysts Say Competing Offers Likely After Rumored AT&T Deal For Consumer Optics Business: Retail’s Excited
Raymond James said the adverse reaction of Lumen stock is due to the deal value being lower than the $6 billion to $9 billion stated by a Reuters report in December. 
Via Stocktwits
Financial Markets Report For Tuesday, March 25
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Tuesday, March 25. 
Via Talk Markets
Topics Commodities Cryptocurrencies Currencies/Forex
Cassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains Hopeful
The drug showed no treatment benefit for patients in the study called REFOCUS-ALZ, the company said, while adding that the Alzheimer’s disease development program with Simufilam will be discontinued by... 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.